AMP's 3rd Annual Molecular Pathology Economics Summit
September 13th, 2023
Omni Shoreham Hotel, Washington D.C.

AMP’s Molecular Pathology Economics Summit will be a highly interactive one-day gathering focused on:

  • Identifying barriers to appropriate reimbursement for molecular pathology procedures;
  • Identifying the impact of these barriers on various stakeholders and patient access to care; and
  • Identifying potential solutions and/or novel approaches to overcoming barriers, with a goal of identifying shared policy agendas for the participating stakeholders in oncology, infectious diseases, and inherited conditions


Please click below to access a summary of themes discussed during the
AMP 2022 Molecular Pathology Economics Summit

Themes button

On July 15th, 2022 AMP held its second Annual Molecular Pathology Economics Summit. Though it was delayed for two years due to the COVID-19 pandemic, this event was a follow up of the first Summit held in 2019. This one-day event brought together 67 attendees ranging from patient advocacy groups, pharmaceutical companies, diagnostic manufacturers, clinical laboratories, as well as trade and professional associations. Robust, candid discussions between stakeholders explored the unique challenges they face, barriers to patient access to molecular diagnostic testing, as well as potential solutions and/or novel approaches to overcoming these barriers, with the goal of identifying shared policy agendas for the participating stakeholders.  Furthermore, AMP held its first ever Innovation Lab where stakeholders were given the opportunity to present their work on expanding patient access to molecular diagnostics as well as build partnerships with other attendees to collaborate on action items to improve patient access in the future.

Notify Me

If you would like to be notified as more information becomes available, please complete this form.

Note Regarding the Ongoing COVID-19 Pandemic:

The safety of our participants is our number one concern. This event is currently being planned as an in-person event. This event will comply with all current DC COVID-19 regulations, and we will keep registrants updated with the full requirements. 



Clifford Goodman, PhD, has 35 years of experience in such areas as health technology assessment, evidence-based health care, clinical practice guidelines, health economics, and studies pertaining to health care innovation, regulation, and payment.  He directs studies and projects for an international range of government agencies; pharmaceutical, biotechnology, and medical device companies; health care provider institutions; and professional, industry, and patient advocacy groups.  His recent work has involved such areas as chronic disease, infectious disease, cancer, rare diseases, diagnostic testing, gene therapy, pharmacogenomics, personalized medicine, biosimilars, value frameworks, value-based contracting, social determinants of health, and applications of real-world data.  Dr. Goodman is an internationally recognized health policy issues moderator and facilitator of expert panels, advisory boards, workshops, and focus groups. 

Dr. Goodman served as chair of the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC, 2009-12) for the Centers for Medicare and Medicaid Services (CMS).  He served as president of the professional society, Health Technology Assessment international (HTAi, 2011-13), and is a Fellow of the American Institute for Medical and Biological Engineering.  In 2022, he received the David Banta Distinguished Career Award in Health Technology Assessment from HTAi.  He earned a PhD from The Wharton School of the University of Pennsylvania, a Master of Science from The Georgia Institute of Technology, and a Bachelor of Arts from Cornell University. 

After 27 years, including as Senior Vice President, Dr. Goodman recently retired from The Lewin Group and is an independent consultant in health care technology and policy.



Preview and Preliminary Agenda of the 2023 Summit

The agenda for this event is still to be determined! If you want a an idea of the potential topics and format please check out the 2022 Summit Agenda.

Please reach out to us at if you are interested in getting updates about the 2023 Summit.


Summit Planning Committee

AMP Economic Affairs Committee Chair
Samuel K. Caughron, MD
MAWD Pathology Group, P.A.

AMP Economic Affairs Committee Vice Chair: Coverage Decisions
Pranil Chandra, DO
PathGroup, LLC

AMP Economic Affairs Committee Vice Chair: New Codes and Pricing
Jay Patel, MD
ARUP Laboratories

AMP Economic Affairs Committee Member
Erin Graf, BS, PhD
Mayo Clinic

AMP Economic Affairs Committee Member
Keyur Patel, MD, PhD
Anderson Cancer Center

AMP Economic Affairs Committee Member
Victoria M. Pratt, PhD, FACMG
Agena Bioscience

AMP Economic Affairs Committee Member
Ester Stein, BS, MBA

AMP Economic Affairs Committee Member
Eric Vail, MS, MD
Cedars-Sinai Medical Center

AMP Economic Affairs Committee Member
Heather E. Williams, MS, PhD
King's College Hospital/Viapath


Government Relations Consultants: iPolicy Solutions
Jennifer Leib, ScM, CGC

Megan Anderson Brooks, PhD

Lindsey Trischler, MPAP

Government Relations Consultants: CRD Associates
Erika Miller, JD

Michaela Hollis, MPH

Stefanie Rinehart, JD, MPH

Registration Information

Registration pricing is for a single individual. Please select your registration type based on your current organization. To register for this event 1.) click Register (above) 2.) either login using your AMP credentials or scroll down to create a new account.

IMPORTANT: Participation is limited and we encourage you to register and reserve your space as soon as possible. We anticipate that this event will sell-out. 

Registration Type  Advanced Registration
(Until August 13th)
(August 14th Onward)
Associations & Patient Advocacy Groups* First Attendee from your organization is FREE First Attendee from your organization is FREE
Non-Profit Organizations $375 USD $400 USD
For-Profit Organizations** $950 USD $1,150 USD

*Association and Patient Advocacy Groups - The first attendee from any association or patient advocacy group will receive free registration. Additional registrants from any association or patient advocacy group must register at the Non-Profit registration rate. To access your free registration (or to confirm if you are the first registrant), please contact the AMP Public Policy and Advocacy Department at:

**Corporate Advisory Council members may receive free registration as a benefit of AMP Partnership. Please contact Laurie Menser ( regarding these registrations.

Cancellation Policy: Cancellations received by written notification to through August 1st will receive a refund (less a $100 processing fee). No refunds after August 1st.

Pay by Check: To pay by check please contact us at

Registration Instructions:

1.) Click the Register Now button above

2.) Login using your AMP credentials or conduct a password reset

3.) Don't have a AMP credentials? Click "New User? Click Here" to create an account

4.) Once logged in, click "Events" at the top of the page

5.) Select the Molecular Pathology Economics Summit and proceed.

If you have any questions during the registration proces contact us at

Hotel & Travel Information

The 2023 AMP Molecular Pathology Economics Summit will be held at the Omni Shoreham Hotel, Washington DC.  AMP has negotiated with the host venue to provide attendees with the discounted room rate of $239.00 (USD) per night (+applicable taxes and fees).  The Hotel Reservation Deadline is August 22, 2023.

Book Your Room
Guests may also reserve rooms by calling 1-800-THE-OMNI and referencing the EAC Summit 2023 Room Block.
Travel & Airport Information




For more information on becoming an Industry Partner for this event please contact, Laurie Menser.

Corporate Partners